XML 27 R16.htm IDEA: XBRL DOCUMENT v3.20.2
SIGNIFICANT ACCOUNTING POLICIES (Tables)
 9 Months Ended
Sep. 30, 2020
Accounting Policies [Abstract]  
Service Fee Revenue
Our total service revenues during the three and nine months ended September 30, 2020 and 2019 are presented in the table below based on an allocation of the estimated transaction price with the patient between the primary patient classification of insurance coverage (in thousands):
 Three Months Ended
September 30,		Nine Months Ended
September 30,
2020201920202019
Commercial insurance$160,524 $163,152 $412,415 $475,064 
Medicare62,704 61,599 154,847 175,825 
Medicaid7,098 7,128 18,072 21,564 
Workers' compensation/personal injury7,183 10,865 25,705 32,950 
Other patient revenue8,328 6,085 17,211 17,947 
Management fee revenue2,675 1,792 8,574 5,662 
Teleradiology and Software revenue2,349 4,412 8,319 12,861 
Other5,869 6,875 15,617 20,878 
Service fee revenue256,730 261,908 660,760 762,751 
Revenue under capitation arrangements35,046 30,784 103,145 90,587 
Total service revenue$291,776 $292,692 $763,905 $853,338 
Schedule of goodwill and other intangible assets Activity in goodwill for the nine months ended September 30, 2020 is provided below (in thousands):
Balance as of December 31, 2019$441,973 
Goodwill acquired through the acquisition of Olney Open MRI, LLC601 
Goodwill acquired through the acquisition of MRI at Woodbridge, LLC1,833 
Goodwill acquired through the acquisition of DeepHealth, Inc.23,396 
Goodwill acquired through the acquisition of AZ-Tech Radiology & Open MRI, LLC2,882 
Balance as of September 30, 2020$470,685 
Effect of derivative instruments on comprehensive income A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive loss of the 2016 Caps is as follows (amounts in thousands):
For the three months ended September 30, 2020
AccountJuly 1, 2020 BalanceAmount of comprehensive gain recognized on derivative net of taxesSeptember 30, 2020 BalanceLocation
Accumulated Other Comprehensive Loss, net of taxes(1,409)195 (1,214)Liabilities and Equity
For the nine months ended September 30, 2020
AccountJanuary 1, 2020 BalanceAmount of comprehensive gain recognized on derivative net of taxesSeptember 30, 2020 BalanceLocation
Accumulated Other Comprehensive Loss, net of taxes(1,877)663 (1,214)Liabilities and Equity
A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive loss of the 2019 swaps which remain ineffective is as follows (amounts in thousands):
For the three months ended September 30, 2020
AccountJuly 1, 2020 BalanceAmount of comprehensive loss recognized on derivative net of taxesAmount of loss reclassified out of accumulated OCI into income (prior period effective portion), net of taxesSeptember 30, 2020 BalanceLocation
Accumulated Other Comprehensive Loss, net of taxes$(24,406)$— $969 $(23,437)Liabilities and Equity
For the nine months ended September 30, 2020
AccountJanuary 1, 2020 BalanceAmount of comprehensive loss recognized on derivative net of taxesAmount of loss reclassified out of accumulated OCI into income (prior period effective portion), net of taxesSeptember 30, 2020 BalanceLocation
Accumulated Other Comprehensive Loss, net of taxes$(5,870)$(19,428)$1,861 $(23,437)Liabilities and Equity
A tabular presentation of the effect of derivative instruments on our statement of operations of the 2019 Swaps for the Swaps that became ineffective during the third quarter is as follows (amounts in thousands):
For the three months ended September 30, 2020
Ineffective interest rate swapAmount of loss recognized in income on derivative (current period ineffective portion)Location of loss recognized in Income on derivative (current period ineffective portion)Amount of loss reclassified from accumulated OCI into income (prior period effective portion)Location of gain (Loss) reclassified from accumulated OCI into income (prior period effective portion)
Interest rate contracts$(679)Other income (expense)$(1,312)Equity and Interest Expense
Schedule of fair value of assets and liabilities The tables below summarize the estimated fair values of certain of our financial assets that are subject to fair value measurements, and the classification of these assets on our condensed consolidated balance sheets, as follows (in thousands):
 As of September 30, 2020
Level 1Level 2Level 3Total
Current and long term liabilities    
2016 caps - Interest Rate Contracts$— $182 $— $182 
2019 swaps - Interest Rate Contracts$— $39,983 $— $39,983 
 As of December 31, 2019
Level 1Level 2Level 3Total
Current and long term liabilities    
2016 caps - Interest Rate Contracts$— $1,081 $— $1,081 
2019 swaps - Interest Rate Contracts$— $9,477 $— $9,477 
The table below summarizes the estimated fair value compared to our face value of our long-term debt as follows (in thousands):
 As of September 30, 2020
Level 1Level 2Level 3Total Fair ValueTotal Face Value
First Lien Term Loans and SunTrust Term Loan$— $663,140 $— $663,140 $673,227 
 As of December 31, 2019
Level 1Level 2Level 3TotalTotal Face Value
First Lien Term Loans and SunTrust Term Loan$— $708,948 $— $708,948 $705,699 
Earnings per share Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):
 Three Months Ended September 30,Nine Months Ended September 30,
2020201920202019
Net income (loss) attributable to RadNet, Inc.'s common stockholders$6,156 $3,195 $(20,797)$4,360 
BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS
Weighted average number of common shares outstanding during the period51,358,603 49,807,460 50,746,380 49,597,138 
Basic net income (loss) per share attributable to RadNet, Inc.'s common stockholders$0.12 $0.06 $(0.41)$0.09 
DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS
Weighted average number of common shares outstanding during the period51,358,603 49,807,460 50,746,380 49,597,138 
Add nonvested restricted stock subject only to service vesting120,605 200,567 191,375 
Add additional shares issuable upon exercise of stock options and warrants476,607 352,333 324,793 
Weighted average number of common shares used in calculating diluted net income per share51,955,815 50,360,360 50,746,380 50,113,306 
Diluted net income (loss) per share attributable to RadNet, Inc.'s common stockholders$0.12 $0.06 $(0.41)$0.09 
Stock options and non vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:
Nonvested restricted stock subject to service vesting— — 331,659 — 
Shares issuable upon the exercise of stock options:48,948 — 933,370 — 
Investment in joint ventures
The following table is a summary of our investment in joint ventures during the nine months ended September 30, 2020 (in thousands):
Balance as of December 31, 2019$34,470 
Equity in earnings in these joint ventures5,176 
Distribution of earnings(5,706)
Equity contributions in existing joint ventures1,631 
Balance as of September 30, 2020$35,571 
Joint venture investment and financial information
The following table is a summary of key balance sheet data for these joint ventures as of September 30, 2020 and December 31, 2019 and income statement data for the nine months ended September 30, 2020 and 2019 (in thousands):
Balance Sheet Data:September 30, 2020December 31, 2019
Current assets$26,618 $27,427 
Noncurrent assets70,576 61,037 
Current liabilities(10,487)(9,217)
Noncurrent liabilities(22,751)(18,872)
Total net assets$63,956 $60,375 
Book value of RadNet joint venture interests$29,121 $28,001 
Cost in excess of book value of acquired joint venture interests and other6,450 6,469 
Total value of Radnet joint venture interests$35,571 $34,470 
Total book value of other joint venture partner interests$34,835 $32,374 
Income statement data for the nine months ended September 30,20202019
Net revenue$78,988 $80,115 
Net income$13,651 $13,718